| Secondary, AA, Amyloidosis |
23 |
| A Review of Osteoporosis in the Older Adult: An Update |
13 |
| Minimal Clinically Important Difference A Review of Outcome Measure Score Interpretation |
11 |
| Gastrointestinal and Hepatic Disease in Systemic Lupus Erythematosus |
9 |
| Propensity Score Methods for Bias Reduction in Observational Studies of Treatment Effect |
9 |
| Maximizing Engagement in Mobile Health Studies Lessons Learned and Future Directions |
8 |
| Idiopathic Inflammatory Myopathies |
6 |
| Update on Cardiovascular Disease Risk in Patients with Rheumatic Diseases |
5 |
| Lumbar Spinal Stenosis in Older Adults |
5 |
| Gastrointestinal Involvement in Behcet Disease |
5 |
| Gastrointestinal and Hepatic Disease in Systemic Sclerosis |
5 |
| Renal Involvement in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis |
5 |
| Renal Manifestations of Rheumatoid Arthritis |
5 |
| Thrombotic Microangiopathies with Rheumatologic Involvement |
5 |
| Anti-Glomerular Basement Membrane Disease |
5 |
| Workforce Trends in Rheumatology |
5 |
| Treat to Target in Rheumatology A Historical Account on Occasion of the 10th Anniversary |
5 |
| Big Data in Rheumatology Intelligent Data Modeling Improves the Quality of Imaging Data |
4 |
| Measuring Patient Preferences An Overview of Methods with a Focus on Discrete Choice Experiments |
4 |
| Should Methotrexate Have Any Place in the Treatment of Psoriatic Arthritis? |
4 |
| Is There a Role for MRI to Establish Treatment Indications and Effectively Monitor Response in Patients with Axial Spondyloarthritis? |
4 |
| Update on Sjogren Syndrome and Other Causes of Sicca in Older Adults |
4 |
| Nonsurgical Management of Osteoarthritis Knee Pain in the Older Adult: An Update |
4 |
| Gastrointestinal and Hepatic Disease in the Inflammatory Myopathies |
4 |
| Gastrointestinal and Hepatic Disease in Sjogren Syndrome |
4 |
| Are the Current Recommendations for Chloroquine and Hydroxychloroquine Screening Appropriate? |
3 |
| Vascular Consequences of Hyperuricemia and Hypouricemia |
3 |
| Therapy for Proliferative Lupus Nephritis |
3 |
| Digital Medicine in Rheumatology Challenges and Opportunities |
3 |
| Challenges in Optimizing Medical Education for Rheumatologists |
3 |
| Challenges in Implementing Treat-to-Target Strategies in Rheumatology |
3 |
| Using Health Information Technology to Support Use of Patient-Reported Outcomes in Rheumatology |
3 |
| Digital Interventions to Build a Patient Registry for Rheumatology Research |
3 |
| Treat to Target in Systemic Lupus Erythematosus |
3 |
| Treat to Target A Valid Concept for Management of Polymyalgia Rheumatica and Giant Cell Arteritis? |
2 |
| Mobile Apps for Rheumatoid Arthritis Opportunities and Challenges |
2 |
| Patient Self-Management and Tracking A European Experience |
2 |
| Motivational Counseling and Text Message Reminders For Reduction of Daily Sitting Time and Promotion of Everyday Physical Activity in People with Rheumatoid Arthritis |
2 |
| Project ECHO Telehealth to Expand Capacity to Deliver Best Practice Medical Care |
2 |
| The Challenges of Approaching and Managing Gout |
2 |
| Strategies for Dealing with Missing Accelerometer Data |
2 |
| Pharmacotherapy Pearls in Rheumatology for the Care of Older Adult Patients Focus on Oral Disease-Modifying Antirheumatic Drugs and the Newest Small Molecule Inhibitors |
2 |
| Intra-articular Hyaluronan Therapy for Symptomatic Knee Osteoarthritis |
2 |
| Gastrointestinal and Hepatic Disease in Vasculitis |
2 |
| Rheumatic Manifestations in Autoimmune Liver Disease |
2 |
| Acute and Chronic Tubulointerstitial Nephritis of Rheumatic Causes |
2 |
| Renal Manifestations of Inflammatory Bowel Disease |
2 |
| Autoimmune Kidney Diseases Associated with Chronic Viral Infections |
1 |
| Gastrointestinal and Hepatic Disease in Fibromyalgia |
1 |
| Gastrointestinal and Hepatic Disease in Rheumatoid Arthritis |
1 |
